Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis

Lindsay Armstrong-Buisseret, Clare Brittain, Miruna David, Gillian Dean, Frances Griffiths, Trish Hepburn, Louise Jackson, Joe Kai, Alan Montgomery, Tracy Roberts, Sukhwinder Thandi, Jonathan D.C. Ross*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Scopus)
    Original languageEnglish
    Article number648
    JournalTrials
    Volume20
    Issue number1
    DOIs
    Publication statusPublished (VoR) - 27 Nov 2019

    Keywords

    • Antibiotic usage
    • Bacterial vaginosis
    • Cost-benefit analysis
    • Lactic acid gel
    • Metronidazole
    • Recurrence
    • VITA

    Fingerprint

    Dive into the research topics of 'Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis'. Together they form a unique fingerprint.

    Cite this